TSC1/TSC2 and Rheb Have Different Effects on TORC1 and TORC2 Activity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2006 Apr 22

PMID 16627617

Citations 90

Authors

Qian Yang

Ken Inoki

Eunjung Kim

Kun-Liang Guan

Affiliations

Soon will be listed here.

Abstract

Target of rapamycin (TOR) plays a central role in cell growth regulation by integrating signals from growth factors, nutrients, and cellular energy levels. TOR forms two distinct physical and functional complexes, termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2). TORC1, which is sensitive to rapamycin, regulates translation and cell growth, whereas TORC2, which is insensitive to rapamycin, regulates cell morphology and cell growth. The Ras homology enriched in brain (Rheb) small GTPase is known to be a key upstream activator of TORC1, although the mechanism of Rheb in TORC1 activation remains to be determined. However, the function of Rheb in the TORC2 regulation has not been elucidated. By measuring Akt and S6K phosphorylation as a functional assay for TORC1 and -2, here, we report that dRheb has an inhibitory effect on dTORC2 activity in Drosophila S2 cells. This negative effect of dRheb on dTORC2 is possibly due to a feedback mechanism involving dTORC1 and dS6K. We also observed that Rheb does not activate TORC2 in human embryonic kidney 293 cells, although it potently stimulates TORC1. Furthermore, tuberous sclerosis complex 1 (TSC1) and TSC2, which are negative regulators of Rheb, have negative and positive effects on TORC1 and -2, respectively. Our observations suggest that TSC1/2 and Rheb have different effects on the activity of TORC1 and -2, further supporting the complexity of TOR regulation.

Citing Articles

Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate.

Wang S, Ma R, Gao C, Tian Y, Hu R, Zhang H Stem Cell Res Ther. 2025; 16(1):38.

PMID: 39901197 PMC: 11792405. DOI: 10.1186/s13287-025-04170-3.

Important Roles of PI3K/AKT Signaling Pathway and Relevant Inhibitors in Prostate Cancer Progression.

Wang R, Qu Z, Lv Y, Yao L, Qian Y, Zhang X Cancer Med. 2024; 13(21):e70354.

PMID: 39485722 PMC: 11529649. DOI: 10.1002/cam4.70354.

Role and mechanisms of autophagy, ferroptosis, and pyroptosis in sepsis-induced acute lung injury.

Shen Y, He Y, Pan Y, Liu L, Liu Y, Jia J Front Pharmacol. 2024; 15:1415145.

PMID: 39161900 PMC: 11330786. DOI: 10.3389/fphar.2024.1415145.

Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling.

Rahman M, Nguyen T, Lee G, Kim B, Park M, Lee C Int J Mol Sci. 2024; 25(3).

PMID: 38338768 PMC: 10855792. DOI: 10.3390/ijms25031489.

Stem cell mTOR signaling directs region-specific cell fate decisions during intestinal nutrient adaptation.

Mattila J, Viitanen A, Fabris G, Strutynska T, Korzelius J, Hietakangas V Sci Adv. 2024; 10(6):eadi2671.

PMID: 38335286 PMC: 10857434. DOI: 10.1126/sciadv.adi2671.

References

WALKER E, Pacold M, Perisic O, Stephens L, Hawkins P, Wymann M . Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000; 6(4):909-19. DOI: 10.1016/s1097-2765(05)00089-4. View

Radimerski T, Montagne J, Rintelen F, Stocker H, van der Kaay J, Downes C . dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat Cell Biol. 2002; 4(3):251-5. DOI: 10.1038/ncb763. View

Collins B, Deak M, Murray-Tait V, Storey K, Alessi D . In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J Cell Sci. 2005; 118(Pt 21):5023-34. DOI: 10.1242/jcs.02617. View

Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg M, Hall A . Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 2004; 6(11):1122-8. DOI: 10.1038/ncb1183. View

Jacinto E, Hall M . Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol. 2003; 4(2):117-26. DOI: 10.1038/nrm1018. View

Kamada Y, Fujioka Y, Suzuki N, Inagaki F, Wullschleger S, Loewith R . Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol Cell Biol. 2005; 25(16):7239-48. PMC: 1190227. DOI: 10.1128/MCB.25.16.7239-7248.2005. View

Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo J, Bonenfant D . Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell. 2002; 10(3):457-68. DOI: 10.1016/s1097-2765(02)00636-6. View

Inoki K, Li Y, Zhu T, Wu J, Guan K . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002; 4(9):648-57. DOI: 10.1038/ncb839. View

Ali S, Sabatini D . Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site. J Biol Chem. 2005; 280(20):19445-8. DOI: 10.1074/jbc.C500125200. View

10.

Castro A, Rebhun J, Clark G, Quilliam L . Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem. 2003; 278(35):32493-6. DOI: 10.1074/jbc.C300226200. View

11.

Manning B, Tee A, Logsdon M, Blenis J, Cantley L . Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell. 2002; 10(1):151-62. DOI: 10.1016/s1097-2765(02)00568-3. View

12.

Sarbassov D, Ali S, Kim D, Guertin D, Latek R, Erdjument-Bromage H . Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004; 14(14):1296-302. DOI: 10.1016/j.cub.2004.06.054. View

13.

Fingar D, Blenis J . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004; 23(18):3151-71. DOI: 10.1038/sj.onc.1207542. View

14.

Worby C, Dixon J . RNA interference of gene expression (RNAi) in cultured Drosophila cells. Sci STKE. 2001; 2001(95):pl1. DOI: 10.1126/stke.2001.95.pl1. View

15.

Dan H, Sun M, Yang L, Feldman R, Sui X, Ou C . Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem. 2002; 277(38):35364-70. DOI: 10.1074/jbc.M205838200. View

16.

Lizcano J, Alrubaie S, Kieloch A, Deak M, Leevers S, Alessi D . Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Biochem J. 2003; 374(Pt 2):297-306. PMC: 1223624. DOI: 10.1042/BJ20030577. View

17.

Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J . Rheb binds and regulates the mTOR kinase. Curr Biol. 2005; 15(8):702-13. DOI: 10.1016/j.cub.2005.02.053. View

18.

Brazil D, Hemmings B . Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001; 26(11):657-64. DOI: 10.1016/s0968-0004(01)01958-2. View

19.

Kim D, Sarbassov D, Ali S, Latek R, Guntur K, Erdjument-Bromage H . GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell. 2003; 11(4):895-904. DOI: 10.1016/s1097-2765(03)00114-x. View

20.

Schmidt A, Bickle M, Beck T, Hall M . The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell. 1997; 88(4):531-42. DOI: 10.1016/s0092-8674(00)81893-0. View